Data / Drug companies / Enoxaparin sodium
Enoxaparin sodium: 18 companies and 158 products in the FDA NDC directory
Enoxaparin sodium is listed in the FDA National Drug Code Directory by 18 companies, with 158 products in commercial distribution. 117 of the products (74.1%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are injection; injection, solution, and the newest product started marketing on May 1, 2026.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 18
- Products
- 158
- Generic (ANDA) products
- 117 (74.1%)
- Application numbers
- 11
- Routes
- Subcutaneous, Intravenous
- Brand names
- Lovenox
- openFDA record search
- api.fda.gov
Companies that list enoxaparin sodium
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Fresenius Kabi USA, LLC | 28 | injection | Authorized generics (NDA) | June 18, 2019 |
| Meitheal Pharmaceuticals Inc. | 16 | injection | Generic drugs (ANDA) | June 14, 2022 |
| Sanofi-Aventis U.S. LLC | 16 | injection | New drug applications (NDA) | March 29, 1993 |
| BluePoint Laboratories | 9 | injection | Generic drugs (ANDA) | May 1, 2025 |
| Amphastar Pharmaceuticals, Inc. | 8 | injection | Generic drugs (ANDA) | November 11, 2019 |
| Sanofi-Aventis U.S. LLC | 8 | injection | Authorized generics (NDA) | October 3, 2011 |
| Be Pharmaceuticals Inc. | 7 | injection | Generic drugs (ANDA) | June 16, 2023 |
| Cardinal Health 107, LLC | 7 | injection | Generic drugs (ANDA) | July 16, 2024 |
| Gland Pharma Limited | 7 | injection | Generic drugs (ANDA) | July 11, 2023 |
| Hebei Changshan Biochemical Pharmaceutical Co., Ltd. | 7 | injection | Generic drugs (ANDA) | May 1, 2026 |
| Hepalink USA Inc. | 7 | injection, solution | Generic drugs (ANDA) | March 15, 2023 |
| Italfarmaco SpA | 7 | injection, solution | Generic drugs (ANDA) | April 1, 2021 |
| NorthStar Rx LLC | 7 | injection | Generic drugs (ANDA) | December 1, 2019 |
| NorthStar RxLLC | 7 | injection, solution | Generic drugs (ANDA) | March 15, 2023 |
| Sandoz Inc | 7 | injection | Generic drugs (ANDA) | July 23, 2010 |
| Zydus Pharmaceuticals USA Inc. | 7 | injection, solution | Generic drugs (ANDA) | April 1, 2021 |
| Sagent Pharmaceuticals | 2 | injection | Generic drugs (ANDA) | October 1, 2023 |
| Civica, Inc. | 1 | injection | Generic drugs (ANDA) | November 1, 2025 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Injection | 130 | 82.3% |
| Injection, solution | 28 | 17.7% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 117 | 74.1% |
| Authorized generics (NDA) | 24 | 15.2% |
| New drug applications (NDA) | 17 | 10.8% |
Pharmacologic classes
| Class | Products |
|---|---|
| Low Molecular Weight Heparin | 158 |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.